FDA Cuts Off Monoclonal Antibody Treatments and Ron DeSantis is Fighting Back

The progressive mob is the wind behind the failing Biden administration. In order to try to prop up their interests, the entire Biden machine, including the politicized FDA & NIH, is targeting Florida Governor Ron DeSanti’s effort to keep his state open while helping obtain treatments for those with COVID.

The Florida Department of Health announced Monday that the U.S. Food and Drug Administration (FDA) made an “abrupt decision to remove emergency use authorization for two monoclonal antibodies,” which effectively shut down treatment sites statewide.

The FDA said in its statement that it is removing the authorization because the treatments “are highly unlikely to be active against the omicron variant.”

“Florida disagrees with the decision that blocks access to any available treatments in the absence of clinical evidence,” the Florida Health Department blasted in a press release. “To date, such evidence has not been provided by the United States Food and Drug Administration (FDA).”

DeSantis shot back at the Biden administration for pulling the medicines, claiming the federal government withdrew the treatments without evidence.

“Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law,” DeSantis said in a scathing statement:

“This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives,” he continued. “There are real-world implications to Biden’s medical authoritarianism – Americans’ access to treatments is now subject to the whims of a failing president.”

Because of the Biden administration’s actions, 2,000 Floridians who had appointments to receive such treatments had their appointments canceled this week.

DeSantis’s office:

This decision was made solely by Biden’s Food and Drug Administration (FDA) without advance warning to states or health providers and without clinical data to support the decision. The deliberate decision by the Biden Administration to make this announcement effective immediately, through a press release, actively prevents states and health care providers from making real-time operational decisions that save lives.

The FDA statement reads.

“In the future, if patients in certain geographic regions are likely to be infected or exposed to a variant that is susceptible to these treatments, then use of these treatments may be authorized in these regions,”

In light of the most recent information and data available, today, the FDA revised the authorizations for two monoclonal antibody treatments – bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) – to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments. 

Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequency throughout the United States, these treatments are not authorized for use in any U.S. states, territories, and jurisdictions at this time. In the future, if patients in certain geographic regions are likely to be infected or exposed to a variant that is susceptible to these treatments, then use of these treatments may be authorized in these regions.  

In September, Florida Governor Ron DeSantis (R) secured additional doses of the potentially life-saving treatment despite the Biden administration taking control of the treatment and effectively reducing Florida’s necessary supply.

The Biden administration announced in September that they’d be rationing supply of the treatment, effectively cutting supply from COVID-positive Floridians:

As reported by Fortune, “Hospitals and other care providers will no longer be able to directly order monoclonal antibody therapies from distributors, according to a Sept. 13 update posted on the Department of Health and Human Services website.”

“Instead, the U.S. government will determine what quantity of the drugs to ship to each state and territory based on Covid-19 case numbers and use of the treatments locally. State health departments will then determine how to distribute the antibody therapies to hospitals and other sites, according to the HHS update,” the outlet added.

The move was made to apparently limit potential shortages elsewhere, though there aren’t any signs of a treatment shortage. The takeover was widely criticized and even deemed an act of “partisan payback” by Senator Marco Rubio (R-FL).

Antibody treatments aren’t a substitute for vaccines. But they have prevented thousands of hospitalizations including in breakthrough cases,” Rubio posted to Twitter. “Now in a move that reeks of partisan payback against states like Florida, the Biden administration is rationing these treatments.”

For those who had previously denied the existence of the “Deep State”, the fact that the FDA, NIH, and FBI have all gone to the far left, political dark side, must now join the real world and be prepared to fight for leadership changes in all levels of government.

Vote conservative in 2022 and 2024.

Written By: Eric Thompson, host of the Eric Thompson Show.

 

Follow Eric on his website ETTALKSHOW, and social media platforms, MAGABOOKTwellit & Twitter.   

Save Up To 66% On MyPillow Products – Use Promo Code ETTALK

 PureTalk – Save Big Money On Your Cell Phone Bill 

This story syndicated with permission from Eric Thompson Show

This story syndicated with permission from Chad Prather